RNF5 and breast cancer: The endoplasmic reticulum (ER)-localized 18-kDa RING finger E3 ligase RNF5, also named RMA1, is commonly expressed in tumor cells with the highest expression in breast cancer and melanoma cells and specimens, and the RNF5 expression level is negatively correlated with survival in breast cancer patients [24].